Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/103338
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma |
Author: | Mrozik, K. Cheong, C. Hewett, D. Chow, A. Blaschuk, O. Zannettino, A. Vandyke, K. |
Citation: | British Journal of Haematology, 2015; 171(3):387-399 |
Publisher: | Wiley |
Issue Date: | 2015 |
ISSN: | 0007-1048 1365-2141 |
Statement of Responsibility: | Krzysztof M. Mrozik, Chee Man Cheong, Duncan Hewett, Annie W.S. Chow, Orest W. Blaschuk, Andrew C.W. Zannettino and Kate Vandyke |
Abstract: | Elevated expression of the cell adhesion molecule N-cadherin (cadherin 2, type 1, N-cadherin (neuronal); CDH2) is associated with poor prognosis in newly-diagnosed multiple myeloma (MM) patients. In this study, we investigated whether targeting of N-cadherin represents a potential treatment for the ~50% of MM patients with elevated N-cadherin. Initially, we stably knocked-down N-cadherin in the mouse MM plasma cell (PC) line 5TGM1 to assess the functional role of N-cadherin in MM pathogenesis. When compared with 5TGM1-scramble-shRNA cells, 5TGM1-Cdh2-shRNA cells had significantly reduced adhesion to bone marrow endothelial cells. However, N-cadherin knock-down did not affect 5TGM1 cell proliferation or adhesion to bone marrow stromal cells. In the C57BL/KaLwRij murine MM model, mice intravenously inoculated with 5TGM1-Cdh2-shRNA cells showed significantly decreased tumour burden after 4 weeks, compared with animals bearing 5TGM1-scramble-shRNA cells. Finally, the N-cadherin antagonist ADH-1 had no effect on tumour burden in the established disease setting, whereas up-front ADH-1 treatment resulted in significantly reduced tumour burden after 4 weeks. Our findings demonstrate that Ncadherin may play a key role in the extravasation of circulating MM PCs promoting bone marrow homing. Moreover, these studies suggest that Ncadherin may represent a viable therapeutic target to prevent the dissemination of MM PCs and delay MM disease progression. |
Keywords: | multiple myeloma; N-cadherin; adhesion; extravasation; ADH-1 |
Rights: | © 2015 John Wiley & Sons Ltd British Journal of Haematology, 2015, 171, 387–399 |
DOI: | 10.1111/bjh.13596 |
Published version: | http://dx.doi.org/10.1111/bjh.13596 |
Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.